Concepedia

Karen Morris

KM

17

Publications

2.9K

Citations

16

H-Index

2010

Active since

Affiliations

Cancer Research UK Manchester Institute(Current)

University of Manchester

The Christie NHS Foundation Trust

Manchester Academic Health Science Centre

Cancer Research UK

Karen Morris is an author at Cancer Research UK Manchester Institute specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

2010–2023

17

Publications

17

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

Jian-Mei Hou, Matthew Krebs, Lee Lancashire et al. · Journal of Clinical Oncology · 2012 · 833 citations · Full text

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer

Cassandra L. Hodgkinson, Christopher J. Morrow, Yaoyong Li et al. · Nature Medicine · 2014 · 682 citations

, , +13

Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer

Louise Carter, Dominic G. Rothwell, Bárbara Mesquita et al. · Nature Medicine · 2016 · 300 citations

, , +13

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

Juan W. Valle, Harpreet Wasan, Andre Lopes et al. · The Lancet Oncology · 2015 · 276 citations · Full text

, , +8

A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer

Sarah Halford, Gareth J. Veal, Stephen R. Wedge et al. · Clinical Cancer Research · 2023 · 177 citations · Full text

Rows per page

1–5 of 17